Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
about
Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeCucurbitacins - An insight into medicinal leads from natureBitter melon: a panacea for inflammation and cancerMomordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genesAntidiabetic effect of Withania coagulans in experimental rats.Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.Inhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantiaSaponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter GourdHypoglycemic herbs and their action mechanisms.Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.An overview of Indian novel traditional medicinal plants with anti-diabetic potentialsDiabetes is an inflammatory disease: evidence from traditional Chinese medicines.Mechanism of action of natural products used in the treatment of diabetes mellitus.Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.Updates on chemical and biological research on botanical ingredients in dietary supplements.Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia.Whole food approach for type 2 diabetes prevention.Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.Momordica charantia: a popular health-promoting vegetable with multifunctionality.Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.Awareness and current knowledge of breast cancer.Cycloartanes from the gum resin of Gardenia gummifera L.f.Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency.Phytotherapy in the Management of Diabetes: A Review.Recent Advances in Momordica charantia: Functional Components and Biological Activities.Influence of sodium chloride treatment and polysaccharides as debittering agent on the physicochemical properties, antioxidant capacity and sensory characteristics of bitter gourd (Momordica charantia) juice.Ethanol Extract Attenuates H₂O₂-Induced Cell Death by Its Antioxidant and Anti-Apoptotic Properties in Human Neuroblastoma SK-N-MC Cells
P2860
Q28081950-33F919F1-8B1C-46B1-B04C-B5BC5734D05EQ28082425-EDF96EC2-2B4B-4471-930F-B82FC82D9B0EQ28817944-7342671D-9062-44F2-9468-B2FD3F448E0AQ33619889-1A55042B-294A-4B31-BC2E-37FDB8E8B24FQ34459142-79D16CE0-FF9C-4812-8CAF-E7907009EDE9Q35073237-2CA86DB5-BA37-497B-B71F-15D6C27E9F20Q35841795-0740AF22-9DA7-4AF8-A324-1941AC4C339DQ36075647-D0C93BEF-0A67-4A9A-8FDF-028692DF86AAQ36752298-D57C0452-F6CB-45E3-BDB2-D4DF21A44278Q37246475-A65A9405-457F-4F5B-8A53-FCB101755630Q37613790-5C55203B-E56C-4754-B086-E23FD406C593Q37693778-DBBD62CB-4976-41E0-B605-7FB53B2827CFQ37825944-309CBB14-1DF2-44D8-B3AD-08465B60E1E7Q37914071-57FFD123-E3CB-4C2B-8EB4-97B39F7EDEF9Q37941680-88BDF0CB-2943-4258-911A-66D764479827Q38074348-123B7ACF-3816-44C2-9E4F-A40E7A2F7B58Q38779824-5B18BFE2-06C0-4199-87CD-DFF3E6ACDBBAQ38821885-03E284BE-F967-4737-B9B5-BC1D14A177C4Q38829703-E35A2A4B-232E-4BBC-97AB-30B53FDE99DFQ38907047-197AE008-8D0A-4826-A815-9A3B610FC438Q39285044-809C8A15-B26E-4B4E-9F73-5558377A29CAQ39299548-6DD0E4E1-6310-4FF9-ABE5-3CF9325CAA20Q42176053-48CF71A9-FA28-448D-9516-0433877585EFQ44589275-6828FECF-0EF8-49F1-87B7-2DA619987146Q46316639-CEB1B3F3-4948-4D07-9B8C-D25FFCC8521BQ47132559-50244FEC-A388-4526-918D-41145A631A06Q47210608-F4B2F77A-206F-43DC-82CB-3A1C1994FB99Q47356636-744736C1-9E68-4E5B-9D10-D684433E7D9EQ55091650-CA4E0740-1D0F-4C8F-BFEE-03224E966F44Q58699614-D5B39264-5DFB-42DA-8D3F-41106C8A0E8C
P2860
Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Momordica charantia constituen ...... the isolated major compounds.
@en
Momordica charantia constituen ...... the isolated major compounds.
@nl
type
label
Momordica charantia constituen ...... the isolated major compounds.
@en
Momordica charantia constituen ...... the isolated major compounds.
@nl
prefLabel
Momordica charantia constituen ...... the isolated major compounds.
@en
Momordica charantia constituen ...... the isolated major compounds.
@nl
P2093
P356
P1476
Momordica charantia constituen ...... the isolated major compounds.
@en
P2093
Liva Harinantenaina
Masayuki Uchida
Michi Tanaka
Munehiro Oda
Orie Mogami
Shigeru Takaoka
Yoshinori Asakawa
P304
P356
10.1248/CPB.54.1017
P407
P577
2006-07-01T00:00:00Z